Latest filing published 01 Dec 2010 for Valeant Pharmaceuticals International, Inc., €1.9M.
No signal scores available.
This profile gathers the share dealings of Michel Chouinard across 2 companies, led by Bausch Health Companies Inc. and Valeant Pharmaceuticals International, Inc. The record holds 12 filings, for trades running from 11 March 2010 to 29 November 2010.
Every open-market trade on record is a sale: 7 sales worth €2.9M. Other entries cover 5 option exercises.
The newest entry dates from 1 December 2010: an open-market sale of €1.9M, in Valeant Pharmaceuticals International, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations